# Timing of Optimal Platelet Inhibition After Acute Coronary Syndrome

> **NCT02099422** · — · UNKNOWN · sponsor: **Hôpital de la Timone** · enrollment: 500 (estimated)

## Conditions studied

- Acute Coronary Syndrome
- Coronary Stenting
- Antiplatelet Therapy

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02099422
- **Lead sponsor:** Hôpital de la Timone
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-01
- **Primary completion:** 2015-01
- **Final completion:** 2016-01
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2014-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02099422

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02099422, "Timing of Optimal Platelet Inhibition After Acute Coronary Syndrome". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02099422. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*